title: Tamoxifen therapy for patients with breast cancer.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Litton
authors.forename: Aman
authors.initials: A
authors.lastname: Buzdar
authors.forename: Mariana Chavez
authors.initials: MC
authors.lastname: Mac Gregor
authors.forename: Ana
authors.initials: A
authors.lastname: Gonzalez-Angulo
authors.forename: Gabriel
authors.initials: G
authors.lastname: Hortobagyi
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D047072:Aromatase Inhibitors / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D000077289:Letrozole; D009570:Nitriles / Q000008:administration & dosage*; D017698:Postmenopause; D017697:Premenopause; D012307:Risk Factors; D013629:Tamoxifen / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors; D016896:Treatment Outcome; D014230:Triazoles / Q000008:administration & dosage*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D009570:Nitriles; D014230:Triazoles; D013629:Tamoxifen; D000077289:Letrozole